Global Influenza Vaccine Market Research Report 2023

Report ID: 1825205 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Influenza Vaccine Market Overview
    1.1 Product Overview and Scope of Influenza Vaccine
    1.2 Influenza Vaccine Segment by Type
        1.2.1 Global Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Influenza Vaccine Segment by Application
        1.3.1 Global Influenza Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 6 Months to 3 Years
        1.3.3 > 3 Years
    1.4 Global Influenza Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Influenza Vaccine Revenue 2017-2028
        1.4.2 Global Influenza Vaccine Sales 2017-2028
        1.4.3 Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Influenza Vaccine Market Competition by Manufacturers
    2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Influenza Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Influenza Vaccine Market Competitive Situation and Trends
        2.5.1 Influenza Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue
        2.5.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Vaccine Retrospective Market Scenario by Region
    3.1 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Influenza Vaccine Market Facts & Figures by Country
        3.3.1 North America Influenza Vaccine Sales by Country
        3.3.2 North America Influenza Vaccine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Influenza Vaccine Market Facts & Figures by Country
        3.4.1 Europe Influenza Vaccine Sales by Country
        3.4.2 Europe Influenza Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Influenza Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Influenza Vaccine Sales by Region
        3.5.2 Asia Pacific Influenza Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Influenza Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Influenza Vaccine Sales by Country
        3.6.2 Latin America Influenza Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Influenza Vaccine Sales by Country
        3.7.2 Middle East and Africa Influenza Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Influenza Vaccine Historic Market Analysis by Type
    4.1 Global Influenza Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Influenza Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Influenza Vaccine Price by Type (2017-2022)
5 Global Influenza Vaccine Historic Market Analysis by Application
    5.1 Global Influenza Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Influenza Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Influenza Vaccine Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 CSL
        6.2.1 CSL Corporation Information
        6.2.2 CSL Description and Business Overview
        6.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 CSL Influenza Vaccine Product Portfolio
        6.2.5 CSL Recent Developments/Updates
    6.3 GSK
        6.3.1 GSK Corporation Information
        6.3.2 GSK Description and Business Overview
        6.3.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GSK Influenza Vaccine Product Portfolio
        6.3.5 GSK Recent Developments/Updates
    6.4 Viatris
        6.4.1 Viatris Corporation Information
        6.4.2 Viatris Description and Business Overview
        6.4.3 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Viatris Influenza Vaccine Product Portfolio
        6.4.5 Viatris Recent Developments/Updates
    6.5 AstraZeneca
        6.5.1 AstraZeneca Corporation Information
        6.5.2 AstraZeneca Description and Business Overview
        6.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 AstraZeneca Influenza Vaccine Product Portfolio
        6.5.5 AstraZeneca Recent Developments/Updates
    6.6 Hualan Bio
        6.6.1 Hualan Bio Corporation Information
        6.6.2 Hualan Bio Description and Business Overview
        6.6.3 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Hualan Bio Influenza Vaccine Product Portfolio
        6.6.5 Hualan Bio Recent Developments/Updates
    6.7 Changchun Institute of Biological
        6.6.1 Changchun Institute of Biological Corporation Information
        6.6.2 Changchun Institute of Biological Description and Business Overview
        6.6.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Changchun Institute of Biological Influenza Vaccine Product Portfolio
        6.7.5 Changchun Institute of Biological Recent Developments/Updates
    6.8 Sinovac
        6.8.1 Sinovac Corporation Information
        6.8.2 Sinovac Description and Business Overview
        6.8.3 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Sinovac Influenza Vaccine Product Portfolio
        6.8.5 Sinovac Recent Developments/Updates
    6.9 BCHT
        6.9.1 BCHT Corporation Information
        6.9.2 BCHT Description and Business Overview
        6.9.3 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 BCHT Influenza Vaccine Product Portfolio
        6.9.5 BCHT Recent Developments/Updates
    6.10 Jiangsu GDK
        6.10.1 Jiangsu GDK Corporation Information
        6.10.2 Jiangsu GDK Description and Business Overview
        6.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Jiangsu GDK Influenza Vaccine Product Portfolio
        6.10.5 Jiangsu GDK Recent Developments/Updates
    6.11 KM Biologics
        6.11.1 KM Biologics Corporation Information
        6.11.2 KM Biologics Influenza Vaccine Description and Business Overview
        6.11.3 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 KM Biologics Influenza Vaccine Product Portfolio
        6.11.5 KM Biologics Recent Developments/Updates
7 Influenza Vaccine Manufacturing Cost Analysis
    7.1 Influenza Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Influenza Vaccine
    7.4 Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Influenza Vaccine Distributors List
    8.3 Influenza Vaccine Customers
9 Influenza Vaccine Market Dynamics
    9.1 Influenza Vaccine Industry Trends
    9.2 Influenza Vaccine Market Drivers
    9.3 Influenza Vaccine Market Challenges
    9.4 Influenza Vaccine Market Restraints
10 Global Market Forecast
    10.1 Influenza Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Influenza Vaccine by Type (2023-2028)
    10.2 Influenza Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Influenza Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Influenza Vaccine by Application (2023-2028)
    10.3 Influenza Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Influenza Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (M Doses) & (US$ Million)
    Table 2. Global Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (M Doses) & (US$ Million)
    Table 3. Global Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Influenza Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Influenza Vaccine Sales (M Doses) of Key Manufacturers (2017-2022)
    Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Influenza Vaccine Average Price (USD/Doses) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Influenza Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 16. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 20. North America Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 24. Europe Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 28. Asia Pacific Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 32. Latin America Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 36. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 40. Global Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Influenza Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Influenza Vaccine Price by Type (2017-2022) & (USD/Doses)
    Table 44. Global Influenza Vaccine Sales (M Doses) by Application (2017-2022)
    Table 45. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Influenza Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Influenza Vaccine Price by Application (2017-2022) & (USD/Doses)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 52. Sanofi Influenza Vaccine Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. CSL Corporation Information
    Table 55. CSL Description and Business Overview
    Table 56. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 57. CSL Influenza Vaccine Product
    Table 58. CSL Recent Developments/Updates
    Table 59. GSK Corporation Information
    Table 60. GSK Description and Business Overview
    Table 61. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 62. GSK Influenza Vaccine Product
    Table 63. GSK Recent Developments/Updates
    Table 64. Viatris Corporation Information
    Table 65. Viatris Description and Business Overview
    Table 66. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 67. Viatris Influenza Vaccine Product
    Table 68. Viatris Recent Developments/Updates
    Table 69. AstraZeneca Corporation Information
    Table 70. AstraZeneca Description and Business Overview
    Table 71. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 72. AstraZeneca Influenza Vaccine Product
    Table 73. AstraZeneca Recent Developments/Updates
    Table 74. Hualan Bio Corporation Information
    Table 75. Hualan Bio Description and Business Overview
    Table 76. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 77. Hualan Bio Influenza Vaccine Product
    Table 78. Hualan Bio Recent Developments/Updates
    Table 79. Changchun Institute of Biological Corporation Information
    Table 80. Changchun Institute of Biological Description and Business Overview
    Table 81. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 82. Changchun Institute of Biological Influenza Vaccine Product
    Table 83. Changchun Institute of Biological Recent Developments/Updates
    Table 84. Sinovac Corporation Information
    Table 85. Sinovac Description and Business Overview
    Table 86. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 87. Sinovac Influenza Vaccine Product
    Table 88. Sinovac Recent Developments/Updates
    Table 89. BCHT Corporation Information
    Table 90. BCHT Description and Business Overview
    Table 91. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 92. BCHT Influenza Vaccine Product
    Table 93. BCHT Recent Developments/Updates
    Table 94. Jiangsu GDK Corporation Information
    Table 95. Jiangsu GDK Description and Business Overview
    Table 96. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 97. Jiangsu GDK Influenza Vaccine Product
    Table 98. Jiangsu GDK Recent Developments/Updates
    Table 99. KM Biologics Corporation Information
    Table 100. KM Biologics Description and Business Overview
    Table 101. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 102. KM Biologics Influenza Vaccine Product
    Table 103. KM Biologics Recent Developments/Updates
    Table 104. Production Base and Market Concentration Rate of Raw Material
    Table 105. Key Suppliers of Raw Materials
    Table 106. Influenza Vaccine Distributors List
    Table 107. Influenza Vaccine Customers List
    Table 108. Influenza Vaccine Market Trends
    Table 109. Influenza Vaccine Market Drivers
    Table 110. Influenza Vaccine Market Challenges
    Table 111. Influenza Vaccine Market Restraints
    Table 112. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
    Table 113. Global Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 114. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 115. Global Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 116. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
    Table 117. Global Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 118. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 119. Global Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 120. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
    Table 121. Global Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 122. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 123. Global Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Influenza Vaccine
    Figure 2. Global Influenza Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Influenza Vaccine Market Share by Application in 2021 & 2028
    Figure 6. 6 Months to 3 Years
    Figure 7. > 3 Years
    Figure 8. Global Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Influenza Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Influenza Vaccine Sales (2017-2028) & (M Doses)
    Figure 11. Influenza Vaccine Sales Share by Manufacturers in 2021
    Figure 12. Global Influenza Vaccine Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2021
    Figure 14. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
    Figure 16. Global Influenza Vaccine Sales Market Share by Region in 2021
    Figure 17. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Figure 18. Global Influenza Vaccine Revenue Market Share by Region in 2021
    Figure 19. U.S. Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Influenza Vaccine by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Influenza Vaccine
    Figure 43. Manufacturing Process Analysis of Influenza Vaccine
    Figure 44. Influenza Vaccine Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Frequently Asked Questions
Influenza Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Influenza Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Influenza Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Probe Card

This report aims to provide a comprehensive presentation of the global market for Probe Card, wit ... Read More